Chailease Holding Co (中租控股) has bought COVID-19 insurance for all its 4,000 local employees and Taiwan-based family members of those stationed abroad, the firm said yesterday.
Chailease, the nation’s top capital leasing service provider, said it would also offer paid leave for those receiving COVID-19 vaccines, as well as disburse quarantine hotel expenses.
The program is necessary due to a local outbreak of COVID-19 and continued spread of the virus throughout Asia, the company said in a statement.
Photo: Lee Chin-hui, Taipei Times
As part of its disease prevention efforts, Chailease distributed NT$3,000 (US$107.79) of food supplements, masks and hygiene products to each of its employees prior to the Lunar New Year holiday in February, it said.
The firm, based in Taipei’s Neihu District (內湖), also offers free stays at its Park City Hotel (成旅晶贊) branches in Taipei, New Taipei City, Taichung and Hualien to frontline medical workers, police officers and firefighters, Chailease said, adding that the campaign is running from June trough the end of this month.
It aims to help frontline workers relax during a free summer vacation, the firm said.
Chailease has also collaborated with its affiliated biotechnology company Protect Life (保生生醫) in donating COVID-19-related medical supplies to local communities, it said.
Healthy earnings lent support to its charity programs, the company said.
Chailease posted NT$10.5 billion in net income for the first six months of this year, 30 percent up year-on-year, or earnings per share of NT$7.11, company data showed.
Chailease attributed the trend to capital leasing demand on local and overseas markets.
Penetration rates for capital leasing remain low in Taiwan and China compared with advanced markets in the US and Europe, suggesting ample room for improvement in Asian markets, the company said.
Among the rows of vibrators, rubber torsos and leather harnesses at a Chinese sex toys exhibition in Shanghai this weekend, the beginnings of an artificial intelligence (AI)-driven shift in the industry quietly pulsed. China manufactures about 70 percent of the world’s sex toys, most of it the “hardware” on display at the fair — whether that be technicolor tentacled dildos or hyper-realistic personalized silicone dolls. Yet smart toys have been rising in popularity for some time. Many major European and US brands already offer tech-enhanced products that can enable long-distance love, monitor well-being and even bring people one step closer to
Malaysia’s leader yesterday announced plans to build a massive semiconductor design park, aiming to boost the Southeast Asian nation’s role in the global chip industry. A prominent player in the semiconductor industry for decades, Malaysia accounts for an estimated 13 percent of global back-end manufacturing, according to German tech giant Bosch. Now it wants to go beyond production and emerge as a chip design powerhouse too, Malaysian Prime Minister Anwar Ibrahim said. “I am pleased to announce the largest IC (integrated circuit) Design Park in Southeast Asia, that will house world-class anchor tenants and collaborate with global companies such as Arm [Holdings PLC],”
Sales in the retail, and food and beverage sectors last month continued to rise, increasing 0.7 percent and 13.6 percent respectively from a year earlier, setting record highs for the month of March, the Ministry of Economic Affairs said yesterday. Sales in the wholesale sector also grew last month by 4.6 annually, mainly due to the business opportunities for emerging applications related to artificial intelligence (AI) and high-performance computing technologies, the ministry said in a report. The ministry forecast that retail, and food and beverage sales this month would retain their growth momentum as the former would benefit from Tomb Sweeping Day
Thousands of parents in Singapore are furious after a Cordlife Group Ltd (康盛人生集團), a major operator of cord blood banks in Asia, irreparably damaged their children’s samples through improper handling, with some now pursuing legal action. The ongoing case, one of the worst to hit the largely untested industry, has renewed concerns over companies marketing themselves to anxious parents with mostly unproven assurances. This has implications across the region, given Cordlife’s operations in Hong Kong, Macau, Indonesia, the Philippines and India. The parents paid for years to have their infants’ cord blood stored, with the understanding that the stem cells they contained